Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 233 - Carboxylic acid amides
Patents for C07C 233 - Carboxylic acid amides (28,881)
12/2005
12/06/2005CA2206787C 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
12/01/2005WO2005113565A2 Metabolites of selective androgen receptor modulators and methods of use thereof
12/01/2005WO2005113558A2 Simple stereocontrolled synthesis of salinosporamide a
12/01/2005WO2005113495A1 Method for producing diphenyl azetidinone derivatives
12/01/2005WO2005113487A2 Polyurea compositions and compounds for the preparation thereof
12/01/2005WO2005113485A2 Stable nateglinide form b compositions
12/01/2005WO2005113484A1 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
12/01/2005WO2005112633A2 Compounds and compositions for delivering active agents
12/01/2005WO2005060603A3 Nitric oxide releasing pyruvate compounds, compositions and methods of use
12/01/2005US20050267316 Chiral diphosphinoterpenes and transition metal complexes thereof
12/01/2005US20050267315 Method for friedel-crafts acylation of anilides
12/01/2005US20050267290 Preparation of acid amides
12/01/2005US20050267207 Thyronamine derivatives and analogs and methods of use thereof
12/01/2005US20050267206 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
12/01/2005US20050267199 2-Amino- and 2-thio- substituted 1,3-diaminopropanes
12/01/2005US20050267168 Pentanoic acid derivatives
12/01/2005US20050267167 Pentanoic acid derivatives
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005US20050267003 Succinic acid semi-amides as anti-corrosives agents
12/01/2005US20050265951 Novel composition containing acyl group
12/01/2005DE102004023522A1 Substituierte Cyclohexyl-1,4-diamin-Derivate Substituted cyclohexyl-1,4-diamine derivatives
12/01/2005CA2567481A1 Method for producing diphenyl azetidinone derivatives
12/01/2005CA2566605A1 Polyurea compositions and compounds for the preparation thereof
12/01/2005CA2566053A1 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
12/01/2005CA2565188A1 Compounds and compositions for delivering active agents
12/01/2005CA2563908A1 Metabolites of selective androgen receptor modulators and methods of use thereof
11/2005
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229334C Inhibitors of alpha4 mediated cell adhesion
11/30/2005CN1229333C N-sigma long chain acyllysine crystals, process for producing same and cosmetics contg. same
11/29/2005US6969775 the shortest synthesis of acetaminophen utilizing the inexpensive commodity chemical p-nitrophenol
11/29/2005US6969732 Central nervous system diosrders; psychological disorders
11/29/2005US6969694 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions
11/24/2005WO2005110974A1 Substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005110973A1 Acid derivatives of substituted cyclohexyl-1,4-diamines
11/24/2005WO2005110972A1 Polymorphic forms of nateglinide
11/24/2005WO2005110971A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005110395A1 System and device for magnetic drug targeting with magnetic drug carrier particles
11/24/2005US20050261371 Administering valproic acid or salts to treat Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis, stroke, and other nervous system disorders
11/24/2005US20050261338 Beta2-adrenergic receptor agonists
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2563793A1 Polymorphic forms of nateglinide
11/23/2005EP1598331A1 Process for the preparation of phthalic acid dichloride
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1597227A1 PROCESS FOR THE PREPARATION OF i N /i -SUBSTITUTED FORMAMIDES
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005EP1320522B1 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1701059A Chemotherapeutic agents
11/23/2005CN1700923A Multi-substituted selective androgen receptor modulators and methods of use thereof
11/23/2005CN1699349A Method and reagents for N-alkylating ureides
11/23/2005CN1228337C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/23/2005CN1228313C Acebutolol synthesis
11/22/2005US6967209 Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide
11/22/2005US6967199 Substituted diamine derivatives useful as motilin antagonists
11/17/2005WO2005108441A2 Polymer having a sulfonic group or a sulfonate group and an amide group and method of producing same
11/17/2005WO2005108409A2 Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts
11/17/2005WO2005108407A1 Cycloolefin phosphine ligands and their use in catalysis
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005108354A1 Use of biphenyl-derived thiamides as calpain inhibitors
11/17/2005WO2005108338A1 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
11/17/2005US20050256336 Crystal forms of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
11/17/2005US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
11/17/2005US20050256201 Phenethanolamine derivatives
11/17/2005US20050256170 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); e.g. (4-[(5-Phenyl-furan-2-carbonyl)-amino]-phenyl)-acetic acid or 5-Phenyl-furan-2-carboxylic acid [3-(1H-tetrazol-5-yl)-phenyl]-amide; dysmenorrhoea, preterm labour, glaucoma, immune disorders, inflammatory disorders
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005US20050256089 for use as pesticides, herbicides; condensation
11/17/2005US20050255138 Active agent transport systems
11/17/2005US20050254319 Polymer bound donor-acceptor-donor compounds and their use in a 3-dimensional optical memory
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2565635A1 Ferrocenyl ligands for homogeneous, enantioselective hydrogenation catalysts
11/17/2005CA2559242A1 Cycloolefin phosphine ligands and their use in catalysis
11/17/2005CA2507477A1 Process for preparing phthaloyl chloride
11/16/2005EP1595888A1 Cycloolefin phosphine ligands and their use in catalysis
11/16/2005EP1595886A1 Chiral diphosphinoditerpenes and their transition metals complexes
11/16/2005EP1595885A2 Chiral diphosphorus compounds and their transition metal complexes
11/16/2005EP1595870A1 Process for producing phenylalanine derivative having quinazolinedione skeleton and intermediate for the same
11/16/2005EP1594856A1 Cb 1/cb 2 receptor ligands and their use in the treatment of pain
11/16/2005EP1594833A1 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
11/16/2005EP1594512A2 Compounds for the treatment of viral infection
11/16/2005EP1487796A4 Substituted biaryl amides as c5a receptor modulators
11/16/2005EP1330464B1 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
11/16/2005CN1227321C Cationic gamini and related multiple hydrophilic/hydrophobic functional compounds and their use as surfactants
11/15/2005US6965052 Synthesis of N-vinyl formamide
11/15/2005US6964985 Mixture of hendenable resin and promoters ; dentistry impressions
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964940 Method of preparing quaternized amidoamine surfactants
11/15/2005CA2387517C Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
11/15/2005CA2266489C N-acetyl aminoethoxyvinylglycine (avg) and its use as an ethylene biosynthesis inhibitor
11/15/2005CA2130944C Ortho-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/10/2005US20050250857 Gelling agents
11/10/2005US20050250848 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
11/10/2005US20050250822 Substituted benzanilide compound and noxious organism controlling agent
11/10/2005US20050250116 Universal supports for oligonucleotide synthesis
11/10/2005US20050249665 Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants
11/10/2005DE19821883B4 Verfahren zur kontinuierlichen Herstellung von Hydroxyalkylamiden A process for the continuous preparation of hydroxyalkylamides
1 ... 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 ... 289